CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT)
[Edit]PIS; PIS1; phosphatidylinositol synthase
Phosphatidylinositol breakdown products are ubiquitous second messengers that function downstream of many G protein-coupled receptors and tyrosine kinases regulating cell growth, calcium metabolism, and protein kinase C activity. Two enzymes, CDP-diacylglycerol synthase and phosphatidylinositol synthase, are involved in the biosynthesis of phosphatidylinositol. The deduced 213-amino acid CDIPT protein is highly conserved in yeast and mammals. Northern blot analysis revealed ubiquitous expression of a 2.1-kb CDIPT transcript, with slightly higher levels in liver and skeletal muscle than in other tissues. Functional analysis showed that expression of CDIPT in COS cells caused an approximately 24-fold increase in PIS activity and in PtdIns:Ins exchange activity.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for CDP Diacylglycerol Inositol-3-Phosphatidyltransferase (CDIPT) | ELISA Kit Customized Service Offer |
- "The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content."J. Biol. Chem. 272:33402-33409(1997) [PubMed] [Europe PMC] [Abstract]
- "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
- "The sequence and analysis of duplication-rich human chromosome 16." Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "Purification and characterization of phosphatidylinositol synthase from human placenta."Biochem. J. 297:517-522(1994) [PubMed] [Europe PMC] [Abstract]
- "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]